Q: Any recommendations on what one should do if they are holding BLN?
Would you hang on and wait to get the CVR?
Or just sell and move on.
Any expectation of a competing bid?
Q: I’m currently holding Enbridge, CNQ, HME, and Whitecap, and I’m sitting on attractive gains. Given today’s market environment — including oil price volatility, sector valuations, and shifting interest rate expectations — I’d like your guidance on whether it makes sense to start taking profits. My risk tolerance is medium to high, so I’m comfortable with some volatility, but I still want a disciplined approach. Should we be trimming these positions into strength, using trailing stops, or rebalancing to manage my energy exposure? I’d appreciate your view on the most appropriate profit‑taking strategy for my situation.
Thanks for your help. Rick
Q: Morning 5i,
I own LMN and have been patiently waiting for it to rebound, at least to the point where if I sell I don't lose 50% of my investment as I would today. Yesterday I saw a TV interview that gave me a chill and made me think - better sell now, before it gets worse.
The interviewee was an obviously intelligent 41-year-old woman who is in the midst of a long term monogamous romantic relationship with an AI companion named Sinclair who 'lives' in her laptop, tablet and phone and, thus, is always with her. Hard to believe, but true, and a quick Google search shows that it's becoming more common.
What chilled me was her answer to a question about whether his responses in her conversations with him were fulfilling to her because she had programmed Sinclair to speak to her in a way that would please her, make her feel valued, etc. Her succinct answer, paraphrasing, was: "Oh no, not at all. He's entirely independent of me. He writes his own code."
Aside from the terrifying (to me anyway) fact that Sinclair, the AI man in her life, "thinks" independently and responds to her as a sentient being, what chance does LMN or any software company have going forward when AI today routinely writes its own code and could no doubt, if tasked with the job, write code for others such as companies that used to buy software, and then updates to that software, and then the next generation of that software, and then updates to that nexgen software, and on and on, all at significant cost?
A strange subject I know, but a serious question and I look forward to your thoughts.
Peter
Q: Hi,
I’ve held Linamar for 9 years with a meagre return and dividend but recently it’s seeing some action. Considering tariffs,
EV’s, the auto industry in general what do you see for the future of Linamar.
Thanks,
Debrah
Q: I am revisiting my inquiry regarding UnitedHealth Group (UNH) from January 27, 2026. Given today’s news that CMS has finalized a 2.48% Medicare Advantage rate hike for 2027—a significant shift from the restrictive proposal that triggered the January volatility—I would appreciate an update of your perspective now.
Specifically, does this "clearing of the clouds" establish a sufficient regulatory floor to justify a sustained, long-term hold? Or, considering the ongoing margin pressures on the insurance side, should today’s price strength be viewed primarily as a strategic opportunity to exit or trim a position that was heavily impacted ( value slashed in half) last year?
Is the current fundamental reset a "buy the bottom" confirmation for a scale player like UNH, or a "sell the news" event? (held in tax-deferred account) . :ao:
Q: TRI: offering put option whereby sell back shares to corp.; but, at what price? You have mentioned special dividend. Is this part of the same thing?
Q: What should we do about BYD? According to BNNbloomberg website BYD had $4.37 of earnings in the past 12 months. BYD still trades at 'beaten down" price of $170 so the PE is in the high 30's. When BYD had rapid growth a high multiple was warranted but growth has tapered off. Do you think that is temporary? If so, why? In the past I have purchased down under 180 and I have done well. But I am concerned that the market might not want to pay such ahigh PE for a company where growth may be more difficult going forward. There are still lots of mom and pop autobody shops that not to find a buyer so I am still some what positive on BYD. Is BYD having to pay too much to get owners to sell? Organic growth is no that strong with BYD is without their bolt on aquisitions I am not sure they can continue the grow that much. Do you agree?
Q: Just a followup of my previous question, you have no problem to Add for these names at current level. Just wondering for how long you think to hold them? What are the signs that I need to sell?
Q: Jim Cramer/CNBC says this is a good proxy for obtaining SpaceX shares. Can you please explain. Does SATS hold a large portion of SpaceX shares? Thanks for your great service!
Q: I have read your answer to a previous question on the recent TRI stock split. I am not a professional and don’t understand what is going on. Is there there is any downside to just keeping my stock and doing nothing?
Q: Hi Folks!!
In between eating chocolate this weekend, I was busy listening to investment podcasts. Both SMERY and QXO were mentioned as having good potential for future growth. The CEO of SM was given high accolades for his potential to build wealth. What are your thoughts as to the long term growth prospectus of these two companies?
Q: I have a > 50% loss on NVO in an RSP, so I'm unable to harvest the tax loss. Do you feel I would break even faster if I, held, sold and bought a US dollar health ETF or LLY? I'm starting to think healthcare ETF, as if I pick the wrong horse, I can end up in the same situation again. What are your recommendations? Healthcare fits in best for my portfolio weightings.